MicroRNA array analysis of microRNAs related to systemic scleroderma

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Rheumatology International

• Publication date

  2012-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s00296-010-1615-yPMID 21052672
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• AP-1 transcription factor decoy reduces the TGF-beta1-induced cell growth in scleroderma fibroblasts through inhibition of cyclin E.

  2008cited by this paper
• Microarray analysis of microRNA expression in peripheral blood cells of systemic lupus erythematosus patients

  2007cited by this paper
• MicroRNAs: Novel Regulators Involved in the Pathogenesis of Psoriasis?

  2007cited by this paper
• Transforming growth factor-β signaling through the Smad proteins: Role in systemic sclerosis

  2006cited by this paper
• MicroRNAs as therapeutic targets.

  2006cited by this paper
• Transforming growth factor-beta signaling through the Smad proteins: role in systemic sclerosis.

  2006cited by this paper
• Expression of interleukin-21 receptor in epidermis from patients with systemic sclerosis.

  2005cited by this paper
• MicroRNA expression profiles classify human cancers

  2005cited by this paper
• Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs

  2005cited by this paper
• miRNAs, cancer, and stem cell division.

  2005cited by this paper
• Monozygotic twins clinically discordant for scleroderma show concordance for fibroblast gene expression profiles.

  2005cited by this paper
• New developments in the pathogenesis of systemic sclerosis

  2005cited by this paper
• The antiangiogenic tissue kallikrein pattern of endothelial cells in systemic sclerosis.

  2005cited by this paper
• Classification analysis of the transcriptosome of nonlesional cultured dermal fibroblasts from systemic sclerosis patients with early disease.

  2005cited by this paper
• Detection of circulating soluble CD28 in patients with systemic lupus erythematosus, primary Sjögren's syndrome and systemic sclerosis

  2004cited by this paper
• A custom microarray platform for analysis of microRNA gene expression

  2004cited by this paper
• Intensified Cloning Efforts Have Revealed Numer

  2004cited by this paper
• The functions of animal microRNAs

  2004cited by this paper
• Systemic and cell type-specific gene expression patterns in scleroderma skin

  2003cited by this paper
• Identification of novel targets in scleroderma: update on population studies, cDNA arrays, SNP analysis, and mutations

  2003cited by this paper
• Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population.

  2003cited by this paper
• Gene expression in bronchoalveolar lavage cells from scleroderma patients.

  2002cited by this paper
• Systemic Sclerosis (Scleroderma): Specific Autoantigen Genes Are Selectively Overexpressed in Scleroderma Fibroblasts1

  2001cited by this paper
• Microchimerism and scleroderma

  1999cited by this paper
• Integrin signaling in fibrosis and scleroderma

  1999cited by this paper
• Mitochondrial diseases in man and mouse.

  1999cited by this paper
• A possible role for transforming growth factor-beta in systemic sclerosis.

  1990cited by this paper
• A Possible Role for Transforming Growth Factor-β in Systemic Sclerosis

  1990cited by this paper

• Differential modulations of miRNAs in patients with systemic sclerosis-associated skeletal muscle loss.

  2025cites this paper
• A review of recent studies on the pathogenesis of Systemic Sclerosis: focus on fibrosis pathways

  2025cites this paper
• Virus-Induced MicroRNA Modulation and Systemic Sclerosis Disease

  2024influential citation
• Circulating Tumor Cells in Cancer Diagnosis, Therapy, and Theranostics Applications: An Overview of Emerging Materials and Technologies.

  2024cites this paper
• In Silico Prediction of NOS2, NOS3 and Arginase 1 Genes Targeting by Micro RNAs Upregulated in Systemic Sclerosis

  2024cites this paper
• Red-light photons on skin cells and the mechanism of photobiomodulation

  2024cites this paper
• Bioinformatics-integrated screening of systemic sclerosis-specific expressed markers to identify therapeutic targets

  2023cites this paper
• miRNA-133 and lncRNA-H19 expressions and their relation to serum levels of PKM2 and TGF-β in patients with systemic sclerosis

  2023cites this paper
• Association between neutrophil/lymphocyte ratio and disease severity in scleroderma patients

  2023cites this paper
• miR-140-5p attenuates hepatic fibrosis by directly targeting TGFβR1

  2023cites this paper
• Probable role of exosomes in the extension of fibrotic alterations from affected to normal cells in systemic sclerosis.

  2022cites this paper
• Novel Concepts in Systemic Sclerosis Pathogenesis: Role for miRNAs

  2021cites this paper
• Crosstalk Between microRNAs and the Pathological Features of Secondary Lymphedema

  2021cites this paper
• Modulation of microRNome by Human Cytomegalovirus and Human Herpesvirus 6 Infection in Human Dermal Fibroblasts: Possible Significance in the Induction of Fibrosis in Systemic Sclerosis

  2021cites this paper
• miR-124-3p targeting of TGF-β1 inhibits the proliferation of hypertrophic scar fibroblasts.

  2021cites this paper
• microRNAs are potentially regulating the survivin gene in PBMCs from systemic sclerosis patients

  2020cites this paper
• The Epigenetic Regulation of Scleroderma and Its Clinical Application.

  2020cites this paper
• The Mechanism of miR-222 Targets Matrix Metalloproteinase 1 in Regulating Fibroblast Proliferation in Hypertrophic Scars

  2020cites this paper
• Epigenetics in Allergy and Autoimmunity

  2020cites this paper
• Redox distress in organ fibrosis: The role of noncoding RNAs

  2020cites this paper
• Serum protein levels of YKL-40 and plasma miR-214 expression in patients with systemic sclerosis

  2020cites this paper
• MicroRNA-140-5p Mediates Renal Fibrosis Through TGF-β1/Smad Signaling Pathway by Directly Targeting TGFBR1

  2020cites this paper
• Epigenetics and systemic sclerosis: An answer to disease onset and evolution?

  2020cites this paper
• A MicroRNA-29 Mimic (Remlarsen) Represses Extracellular Matrix Expression and Fibroplasia in the Skin.

  2019cites this paper
• Epigenetic modulation as a therapy in systemic sclerosis

  2019cites this paper
• Regulation of Fibroblast Apoptosis and Proliferation by MicroRNA‐125b in Systemic Sclerosis

  2019cites this paper
• Role of microRNA in the Pathogenesis of Systemic Sclerosis Tissue Fibrosis and Vasculopathy.

  2019cites this paper
• The function of ncRNAs in rheumatic diseases

  2019cites this paper
• MicroRNA-21 and microRNA-29a modulate the expression of collagen in dermal fibroblasts of patients with systemic sclerosis

  2019cites this paper
• MicroRNA expression analysis of human skin fibroblasts treated with high‐fluence light‐emitting diode‐red light

  2019cites this paper
• Epigenetic Regulation of Myofibroblast Phenotypes in Fibrosis

  2018cites this paper
• MiR-3606-3p inhibits systemic sclerosis through targeting TGF-β type II receptor

  2018cites this paper
• Integration of Genome-Wide DNA Methylation and Transcription Uncovered Aberrant Methylation-Regulated Genes and Pathways in the Peripheral Blood Mononuclear Cells of Systemic Sclerosis

  2018cites this paper
• Systematic approach to understanding the pathogenesis of systemic sclerosis

  2017cites this paper
• Study on the role of Hsa‐miR‐31–5p in hypertrophic scar formation and the mechanism

  2017cites this paper
• [microRNA-222 regulates proliferation and apoptosis of fibroblasts in hypertrophic scar via matrix metalloproteinase 1].

  2017cites this paper
• The histone demethylase Jumonji domain-containing protein 3 (JMJD3) regulates fibroblast activation in systemic sclerosis

  2017cites this paper
• Epigenetics: The Future Direction in Systemic Sclerosis

  2017cites this paper
• Epigenetic factors as drivers of fibrosis in systemic sclerosis.

  2017cites this paper
• MicroRNA-21 in Skin Fibrosis: Potential for Diagnosis and Treatment

  2017cites this paper
• MicroRNAs in the skin: role in development, homoeostasis and regeneration.

  2017cites this paper
• Polymorphisms in miRNA genes and their involvement in autoimmune diseases susceptibility

  2017cites this paper
• Unfolding the pathogenesis of scleroderma through genomics and epigenomics.

  2017cites this paper
• Exosomes isolated from serum of systemic sclerosis patients display alterations in their content of profibrotic and antifibrotic microRNA and induce a profibrotic phenotype in cultured normal dermal fibroblasts.

  2017cites this paper
• A systematic review of overlapping microRNA patterns in systemic sclerosis and idiopathic pulmonary fibrosis

  2017cites this paper
• Protective role for miR-9-5p in the fibrogenic transformation of human dermal fibroblasts

  2016influential citation
• Genetic and epigenetic abnormalities in systemic sclerosis

  2016cites this paper
• MicroRNAs as Biomarkers for Liver Disease and Hepatocellular Carcinoma

  2016cites this paper
• The WNT signalling pathway in systemic sclerosis

  2016cites this paper
• MicroRNAs in skin tissue engineering.

  2015cites this paper
• The Role of MicroRNAs in Autoimmune Diseases with Skin Involvement

  2015cites this paper
• The Circulating Cell-free microRNA Profile in Systemic Sclerosis Is Distinct from Both Healthy Controls and Systemic Lupus Erythematosus

  2015cites this paper
• Genetics, Epigenetics, and Genomics of Systemic Sclerosis.

  2015cites this paper
• MicroRNAs in Skin Fibrosis

  2015cites this paper
• MicroRNAs in Skin Diseases

  2015cites this paper
• Epigenetic mechanisms: An emerging role in pathogenesis and its therapeutic potential in systemic sclerosis.

  2015cites this paper
• Critical roles of microRNAs in the pathogenesis of systemic sclerosis: New advances, challenges and potential directions.

  2015cites this paper
• Role of redoximiRs in fibrogenesis

  2015cites this paper
• Update on biomarkers in systemic sclerosis: tools for diagnosis and treatment

  2015cites this paper
• MicroRNA-130b regulates scleroderma fibrosis by targeting peroxisome proliferator-activated receptor γ

  2015cites this paper
• Downregulation of miR-193b in systemic sclerosis regulates the proliferative vasculopathy by urokinase-type plasminogen activator expression

  2014cites this paper
• The role of genetics and epigenetics in the pathogenesis of systemic sclerosis

  2014cites this paper
• MiR-30a-3p Negatively Regulates BAFF Synthesis in Systemic Sclerosis and Rheumatoid Arthritis Fibroblasts

  2014cites this paper
• Various applications of microRNAs in skin diseases.

  2014cites this paper
• Immuunsüsteemiga seotud mikroRNAde ekspressioon vitiliigohaigete perifeerse vere mononukleaarsetes rakkudes

  2014cites this paper
• Epigenetics of Autoimmune Diseases

  2014cites this paper
• The Journal of Rheumatology from Both Healthy Controls and Systemic Lupus Erythematosus The Circulating Cell-free microRNA Profile in Systemic Sclerosis Is Distinct

  2014cites this paper
• The role of microRNAs in skin fibrosis

  2013influential citation
• Contribution of miRNAs to the pathogenesis of scleroderma and targeting them for the diagnosis and treatment

  2013cites this paper
• Systemic sclerosis: genetics and epigenetics.

  2013cites this paper
• MicroRNAs: their involvement in fibrosis pathogenesis and use as diagnostic biomarkers in scleroderma

  2013cites this paper
• Alteration of circulating miRNAs in SSc: miR-30b regulates the expression of PDGF receptor β.

  2013cites this paper
• MicroRNA-21 in Scleroderma Fibrosis and its Function in TGF-β- Regulated Fibrosis-Related Genes Expression

  2013cites this paper
• Expression analysis of multiple microRNAs in each patient with scleroderma

  2013cites this paper
• MicroRNA expression profiling and target genes study in congenital microtia.

  2013cites this paper
• MicroRNA Expression Abnormalities in Limited Cutaneous Scleroderma and Diffuse Cutaneous Scleroderma

  2012cites this paper
• [microRNA in autoimmune disorders].

  2011cites this paper
• Analytical aspects of microRNA in diagnostics: a review.

  2011cites this paper
• Biomarkers in systemic sclerosis.

  2010cites this paper
• Current world literature.

  2004cites this paper